scout
|Videos|September 26, 2017

Improving Outcomes in Pancreatic Cancer With Perioperative mFOLFIRINOX

Davendra Sohal, MD, MPH, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the need for an ongoing study exploring mFOLFIRINOX versus gemcitabine and nab-paclitaxel (Abraxane) in patients with resectable pancreatic adenocarcinoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME